Federal Awards · EXELAN PHARMACEUTICALS INC · Award

MODIFICATION TO INCORPORATE SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDER…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
36E79722D0026
Contractor
EXELAN PHARMACEUTICALS INC
Sub-agency / office
Department of Veterans Affairs
Award amount
$0
Period of performance
Oct 27, 2022 – —
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
PSC 6505
Competition
FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 8 offers
Pricing
FIRM FIXED PRICE
Financial breakdown
Obligated $0 · Potential value $10,379,934 · Latest action obligation $0

Public award description

MODIFICATION TO INCORPORATE SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO THE CONTRACT.

Most recent · Modification P00012 · Sep 9, 2026 · $0 action obligation · MODIFICATION TO INCORPORATE SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO THE CONTRACT. · 36E79722D0026

Modification P00011 · Mar 23, 2026 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE EXELAN'S 2027 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF APRIL 1, 2026 - MARCH 31, 2027. · 36E79722D0026

Modification P00010 · Sep 23, 2025 · $0 action obligation · EXERCISE OPTION YEAR THREE FOR 36E79722D0026 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 10/27/2025 - 10/26/2026. · 36E79722D0026

Modification P00009 · Apr 15, 2025 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE EXELAN'S 2026 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF APRIL 1, 2025 - MARCH 31, 2026. · 36E79722D0026

Modification P00008 · Sep 25, 2024 · $0 action obligation · EXERCISE OPTION YEAR TWO FOR 36E79722D0026 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 10/27/2024 - 10/26/2025. · 36E79722D0026

Modification P00007 · Apr 30, 2024 · $0 action obligation · CHANGE OF POC TO 36E79722D0026. ADD BARBARA SIGNA. · 36E79722D0026

Modification P00006 · Apr 25, 2024 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE EXELAN'S 2025 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF APRIL 1, 2024 - MARCH 31, 2025 · 36E79722D0026

Modification P00005 · Apr 4, 2024 · $0 action obligation · MODIFICATION FOR THE SUPPLEMENTAL CHANGES TO THE CRF PAYMENT SUBMITTAL AND SALES REPORTING REQUIREMENTS. · 36E79722D0026

Modification P00004 · Jan 30, 2024 · $0 action obligation · CONTRACT ADMINISTRATOR CHANGES EFFECTIVE 1/30/2024 FOR NATIONAL CONTRACT 36E79722D0026, SILDENAFIL CITRATE TABLETS. PRICES REMAIN UNCHANGED. · 36E79722D0026

Modification P00003 · Oct 6, 2023 · $0 action obligation · EXERCISE OPTION YEAR ONE FOR 36E79722D0026 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 10/27/2023 - 10/26/2024. · 36E79722D0026

Modification P00002 · May 11, 2023 · $0 action obligation · UNILATERAL MODIFICATION IS ISSUED TO INCORPORATE UPDATED DSCSA LANGUAGE AND REQUIREMENTS INTO VA NATIONAL CONTRACT 36E79722D0026 · 36E79722D0026

Modification P00001 · Apr 6, 2023 · $0 action obligation · THIS MODIFICATION IS ISSUED TO INCORPORATE EXELAN'S 2023 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF APRIL 1, 2023 - MARCH 31, 2024. · 36E79722D0026

Modification 0 · May 31, 2022 · $0 action obligation · NEW AWARD FOR SILDENAFIL CITRATE TABLETS WITH EXELAN. ORDERING PERIOD IS OCT 27, 2022 TO OCT 26, 2023 WITH FOUR ONE-YEAR OPTIONS · 36E79722D0026

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.